US 12,447,136 B2
Use of (5R,7R,10R)-12,15-dioxo-α-selinene in the preparation of drugs
Yuehu Wang, Kunming (CN); Jifeng Luo, Kunming (CN); Qian He, Kunming (CN); Lu Zhang, Kunming (CN); Shuya Wei, Kunming (CN); and Mengyuan Xia, Kunming (CN)
Assigned to KUNMING INSTITUTE OF BOTANY, CHINESE ACADEMY OF SCIENCES, Kunming (CN)
Appl. No. 17/784,637
Filed by KUNMING INSTITUTE OF BOTANY, CHINESE ACADEMY OF SCIENCES, Kunming (CN)
PCT Filed Jun. 1, 2021, PCT No. PCT/CN2021/097614
§ 371(c)(1), (2) Date Jun. 11, 2022,
PCT Pub. No. WO2021/249236, PCT Pub. Date Dec. 16, 2021.
Claims priority of application No. 202010512412.9 (CN), filed on Jun. 8, 2020.
Prior Publication US 2023/0404946 A1, Dec. 21, 2023
Int. Cl. A61K 31/11 (2006.01); A23L 33/10 (2016.01); A61P 25/28 (2006.01)
CPC A61K 31/11 (2013.01) [A23L 33/10 (2016.08); A61P 25/28 (2018.01)] 13 Claims
 
1. A method of treating Parkinson's disease, comprising administering a pharmaceutical composition comprising a therapeutically effective amount of (5R,7R,10R)-12,15-dioxo-α-selinene to a subject in need thereof.